Story March 4 - Atara Biotherapeutics: While the biotech navigates the fallout from the FDA’s move to halt trials of its allogeneic T-cell immunotherapy Ebvallo and a CAR-T candidate ...

and at the end of last year partnered with Atara on mesothelin-targeted CAR-T cell therapies for solid tumours. Last year it also closed a $4 billion takeover of UK-based Asklepios ...

which has since been followed by the purchase of gene therapy specialist Asklepios Biopharmaceutical in 2020 and a bolt-on deal with Atara Biotherapeutics for mesothelin-targeted CAR-T cell ...

This is the new 2012 Toyota Camry Atara SX. It’s not technically ... This might be due to the car only having done 2000km. They aren’t the largest chairs you’ll find in a family sedan ...

The Ford Mondeo is a medium sized family car. But don’t let the boring stigma associated ... 125kW/226Nm – 1474kg – from $34,450 (auto) Toyota Camry Atara SX – 2.5-litre petrol four ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

Although CD19-directed CAR T cells can initially induce remission in 70-90% of patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL), post-CAR relapses are frequent. These ...

Arovella Therapeutics at forefront of overcoming limitations of CAR-T cell therapy for cancer with its healthy donor-derived ...

Thousands descended on downtown Houston Saturday for the 2025 Art Car Parade. The event is a true celebration of Houston's ...

Nearing its fourth decade of existence, the Houston Art Car Parade will roll through the city’s streets on Aprill 12, greeted by thousands of eager fans cheering on the close to 250 entries.

On Saturday, April 12, 2025, the Houston Art Car Parade will feature 250 cars, a kids zone, VIP packages, and a benefit, starting at 11 a.m. and beginning at 2 p.m.